Skip to main content

2023 Rheumatology Year in Review (1.12.2024)

Join The Discussion

Jagannath chandrashekaran

| Jan 16, 2024 6:52 am

Excellent and exciting times for immunology sector. Its challenging with epidemic proportion of autoimmune conditions encountered daily in clinical practice. We need systematic safe approach to use of new medication biologics and JAK inhibitors with age old medication in hand. We need to inculcate way to reduce the autoimmune trigger factors. We need continuous new updates to keep pace with current trends. Wellcome 2024.

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.